SQI Diagnostics is a diagnostic systems company focused on developing and launching an automated, multiplex immunoassay platform serving the human healthcare market. The Company is initially focused on the autoimmune disease testing segment and is expected to advance its technology into other markets including infectious disease detection and allergen screening. The SQiDworks™ automated platform and the QuantiSpot™ consumable microarray have the potential to significantly reduce processing time, labor thereby reducing overall laboratory test costs by up to 40%.

SQI Diagnostics Inc.(formerly umedik) was founded in 1999 and is focused on the principle that diagnostic technologies commonly used for DNA applications provide a more sensitive and less costly diagnostic solution for protein and antibody detection. For the past six years SQI has been actively developing and integrating the core printing, imaging and assay microarray technologies that form the basis of the automated QuantiSpot™ and SQiDworks™ system capable of generating 960 patient test results per hour.